Le Lézard
Classified in: Health, Business
Subject: ERP

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation


MÖLNDAL, Sweden, Feb. 23, 2024 /PRNewswire/ -- Integrum (publ) (NASDAQ First North Growth Market: INTEG B) will host a webcast presentation of its third quarter 2023/24 results on February 29, 2024 at 14:00 CEST.

Integrum's CEO Rickard Brånemark will present the report together with CFO Jörgen Svanström and US President Jeffrey Zanni in a webcast. The presentation will be held in English.

Time: Thursday, February 29, 2024 at 14:00 CEST.
Location: Webcast (see link below).

The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/

The webcast and presentation material will be accessible via https://www.finwire.tv/webcast/integrum/q3-presentation-2023/ where it is also possible to ask questions.

For more information, please contact:

Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: [email protected]

Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: [email protected]

Certified Adviser

Carnegie Investment Bank AB (publ) is Certified Adviser.

 

The following files are available for download:

https://mb.cision.com/Public/17531/3934582/88a4e18b7e613b00.pdf

2024-02-23 Integrum Invitation to Third Quarter Presentation of Results

SOURCE Integrum AB


These press releases may also interest you

at 10:05
NHS Scotland, in Partnership with Wipro UK Limited, Successfully Implements Rhapsody Enterprise Master Person Index
Rhapsody, a global leader in digital health enablement, today announced that NHS National Services Scotland has successfully implemented Rhapsody Enterprise Master Person Index (EMPI) solution on behalf of NHS Scotland. Hosted in Microsoft Azure,...

at 10:03
Hand to Hold® launches national NICU Graduate Then & Now Photo Contest to kick off graduation season
Hand to Hold, a national nonprofit that provides early intervention mental health support for Neonatal Intensive Care Unit (NICU) parents before, during and after the NICU has announced its 2024 NICU Grad Then & Now Photo Contest. The contest opens...

at 10:03
Harry Hoffman and David Herbert join the HM Venture Partners team as Venture Partners
HM Venture Partners (HMVP), a global healthcare venture capital firm, is thrilled to announce that Harry Hoffman and David Herbert have joined as Venture Partners. In their roles, Harry and David will enrich team structure, broaden proprietary deal...

at 10:00
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
Dipharma Francis S.r.l. (Dipharma), a global Contract Development and Manufacturing Organization (CDMO) and leading manufacturer of New Chemical Entities (NCE), Generic Active Pharmaceutical Ingredients and Advanced Intermediates, proudly announced...

at 10:00
FDA Grants Orphan Drug Designation to 9MW2821
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel Nectin-4-targeting ADC (R&D code: 9MW2821) has been granted Orphan Drug Designation (ODD) by the U.S. Food and...

at 10:00
ODAIA Partners with Veeva to Accelerate Adoption of AI in Life Sciences
Veeva Commercial Summit -- ODAIA today announced it is expanding its product partnership with Veeva Systems, joining the Veeva AI Partner Program to advance the use of Generative AI (GenAI)...

More news about Health...


News published on and distributed by: